CalciMedica, Inc. - Common Stock — 재무제표 (NASDAQ:CALC) | MetaTrader

전체 차트 열기 Full chart

뉴스

칼시메디카, 임상 중단 후 H.C. Wainwright, ’중립’으로 등급 하향

CalciMedica stock downgraded to Neutral by H.C. Wainwright after trial halt

칼시메디카, 2상 KOURAGE 임상시험 중단 권고에 따라 중단

CalciMedica discontinues Phase 2 KOURAGE trial following committee recommendation

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.02%

칼시메디카, 신장 손상 임상 중단 후 주가 폭락

칼시메디카, 안전 문제로 AKI 임상시험 중단

CalciMedica discontinues AKI trial following safety concerns

CalciMedica Pauses Kidney Study, Eyes New Trial In Pancreatitis - CalciMedica (NASDAQ:CALC)

Oppenheimer reiterates Outperform rating on CalciMedica stock ahead of key trial

CalciMedica partners with Telperian to use AI for clinical trial analysis

칼시메디카 CBO, 7,675달러 상당 자사주 매입